'Unicorn' Intarcia files U.S. approval for diabetes implant

(Reuters) - Intarcia Therapeutics Inc said on Monday it submitted a marketing application for its matchstick-size implantable drug-delivery pump for diabetes to the U.S. Food and Drug Administration.